Literature DB >> 11563216

Bayer pulls cerivastatin (Baycol) from market.

E Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563216      PMCID: PMC81435     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

2.  Rhabdomyolysis and cerivastatin: was it a problem of dose?

Authors:  Dipen Kalaria; Willem Wassenaar
Journal:  CMAJ       Date:  2002-10-01       Impact factor: 8.262

Review 3.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 4.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

5.  Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.

Authors:  Alexandra E Rätz Bravo; Lydia Tchambaz; Anita Krähenbühl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Early detection of drug interactions utilizing a computerized drug prescription handling system-focus on cerivastatin-gemfibrozil.

Authors:  Tomás Morera; Guillermo Gervasini; Juan A Carrillo; Julio Benitez
Journal:  Eur J Clin Pharmacol       Date:  2004-01-21       Impact factor: 2.953

7.  Quantification of cerivastatin toxicity supports organismal performance assays as an effective tool during pharmaceutical safety assessment.

Authors:  Shannon M Gaukler; James S Ruff; Tessa Galland; Tristan K Underwood; Kirstie A Kandaris; Nicole M Liu; Linda C Morrison; John M Veranth; Wayne K Potts
Journal:  Evol Appl       Date:  2016-04-15       Impact factor: 5.183

Review 8.  Current and Emerging Uses of Statins in Clinical Therapeutics: A Review.

Authors:  Jonathan T Davies; Spencer F Delfino; Chad E Feinberg; Meghan F Johnson; Veronica L Nappi; Joshua T Olinger; Anthony P Schwab; Hollie I Swanson
Journal:  Lipid Insights       Date:  2016-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.